Epidemiology and Genomics Research
CANCER EPIDEMIOLOGY MATTERS E-NEWS
October 2015
Follow us on Twitter
Funding Opportunity AnnouncementsFundingOpps

PA-15-329
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp)
Application due date: November 30, 2015
Expiration date: December 1, 2015 

RFA-CA-15-024
Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3)
Application due date: February 9, 2016
Expiration date: February 10, 2016

PA-16-005
Collaborative Activities to Promote Metabolomics Research (Admin Supp)
Application due date: February 15, 2016
Expiration date: February 16, 2016

RFA-RM-15-010
Molecular Transducers of Physical Activity Genomics, Epigenomics and Transcriptomics Chemical Analysis Sites (U24)
Application due date: March 18, 2016
Expiration date: March 19, 2016

RFA-RM-15-011
Molecular Transducers of Physical Activity Metabolomics and Proteomics Chemical Analysis Sites (U24)
Application due date: March 18, 2016
Expiration date: March 19, 2016

RFA-RM-15-012
Molecular Transducers of Physical Activity Bioinformatics Center (U24)
Application due date: March 18, 2016
Expiration date: March 19, 2016

RFA-RM-15-013
Molecular Transducers of Physical Activity Preclinical Animal Study Sites (U01)
Application due date: March 18, 2016
Expiration date: March 19, 2016

RFA-RM-15-014
Molecular Transducers of Physical Activity Consortium Coordinating Center (CCC) (U24)
Application due date: March 18, 2016
Expiration date: March 19, 2016

RFA-RM-15-015
Molecular Transducers of Physical Activity Clinical Centers (U01)
Application due date: March 18, 2016
Expiration date: March 19, 2016

RFA-CA-15-007
Planning for Regional Centers of Research Excellence in Non-communicable Diseases in Low and Middle Income Countries (P20)
Application due dates: December 10, 2015; August 23, 2016 
Expiration date: August 24, 2016

Small Business Innovation Research Technology Transfer (R43/44)
Application due dates: Standard dates apply
Expiration date: September 6, 2018 

NCI Prize Competition
Up For a Challenge? Stimulating Innovation in Breast Cancer Genetic Epidemiology
Submissions due January 2016

NOT-OD-16-015
Announcement of NIH Plans for the Environmental Influences on Child Health Outcomes (ECHO) Program 
Grants Policy Announcementsgrantsmanship 

NOT-OD-16-004
NIH & AHRQ Announce Upcoming Changes to Policies, Instructions, and Forms for 2016 Grant Applications

NOT-OD-16-005
NIH & AHRQ Announce Upcoming Changes to Post-Award Forms and Instructions

NOT-OD-16-009
NIH & AHRQ Change Font Guidelines for Applications to Due Dates On or After May 25, 2016

NOT-OD-16-010
Inclusion of Children in Clinical Research: Change in NIH Definition
Job OpportunitiesJob
Master's-Level Fellowship in Environmental Epidemiology

Master's-Level Fellowship in Clinical and Translational Epidemiology
Upcoming Webinars & WorkshopsEvents
November 3, 2015

Cancers and Other NCDs: Forging Global Partnerships Across the U.S. Government
November 3-4, 2015
Bethesda, MD

NCI Cohort Consortium Annual Meeting
November 4-6, 2015
Bethesda, MD 
November 17-18, 2015
Washington, DC
Send Us Your IdeasSendUsIdeas

EGRP encourages readers to submit items of interest to Cancer Epidemiology Matters E-News. EGRP reserves the right to decide whether or not materials are appropriate for inclusion.

About EGRPAboutEGRP
The Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS) funds research in human populations to understand the causes of cancer and related outcomes.

The Program fosters interdisciplinary collaborations, as well as the development and use of resources and technologies to advance cancer research and translation of this research, which serve as the basis for clinical and public health interventions.
Contact UsContactUs
 
email: [email protected]
website: epi.grants.cancer.gov
twitter: twitter.com/NCIEpi
EGRP Leadership TransitionsTransitions

During the past year, the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), which includes the Epidemiology and Genomics Research Program (EGRP), has implemented a long-term effort to revitalize the Division through changes in scientific initiatives, structure and function, culture, and leadership. As a result, EGRP continues to evolve as a Program. Most recently, there have been changes to the senior leadership of EGRP.

Dr. Kathy Helzlsouer Kathy Helzlsouer, M.D., M.H.S., became EGRP's new Associate Director on October 5, 2015. Dr. Helzlsouer also will serve as the Chief Medical Officer for DCCPS. She is board certified in internal medicine and medical oncology. Her research interests are focused on cancer etiology and prevention, cancer survivorship, and clinical and translational research. Dr. Robert Croyle, DCCPS director, said, "Dr. Helzlsouer is a highly accomplished epidemiologist and clinician with a broad vision of cancer epidemiology, prevention, and control. She brings a valuable blend of medical, scientific, and leadership skills, which will be a strong asset for NCI and DCCPS."

Prior to joining NCI, Dr. Helzlsouer was a professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. In 2004, she established the Prevention and Research Center at Mercy Medical Center in Baltimore, Maryland, and she directed the Center until 2015. At the Center, Dr. Helzlsouer led a team of researchers and health care specialists in cancer risk assessments, clinical research, and support programs for cancer patients and their families. She is nationally recognized for her expertise in cancer epidemiology, cancer genetic counseling, and clinical research. In 2012, Dr. Helzlsouer received the Martin D. Abeloff Award for Excellence in Public Health and Cancer Control for her service on the Maryland State Council on Cancer Control. She also is an associate editor of the Journal of the National Cancer Institute and a member of NCI's PDQ� Screening and Prevention Editorial Board.

Muin Khoury, M.D., Ph.D., who had served as EGRP's Acting Associate Director since 2010, is now serving as a Senior Consultant for DCCPS on public health genomics. As EGRP's Acting Associate Director, Dr. Khoury oversaw a period of organizational growth that enabled EGRP to expand the depth and breadth of its scientific expertise and its fellowship training opportunities. During this time, the Program revised its mission and vision statements, changing its name from the "Epidemiology and Genetics Research Program" to the "Epidemiology and Genomics Research Program" to better reflect the full spectrum of supported research and the Program's efforts to implement a robust scientific agenda that spans discovery through translational research to benefit public health. Dr. Khoury also founded and serves as director of the Centers for Disease Control and Prevention's (CDC) Office of Public Health Genomics since 1997.

Dr. Khoury developed the concept for "Trends in 21st Century Epidemiology: From Scientific Discoveries to Population Health Impact," EGRP's public workshop held in Bethesda, Maryland, December 12-13, 2012.  At this workshop, external researchers and thought leaders presented their perspectives on major facets of the epidemiologic enterprise. Eight overarching thematic recommendations from the workshop were published in April 2013. Many activities, initiatives, and research resources that EGRP staff have undertaken over the past few years have built upon or were related to recommendations stemming from the 2012 workshop.

Daniela Seminara, Ph.D., M.P.H., who had served as a Senior Scientist in EGRP since 1997 and as the Cohorts and Consortia Team Lead for EGRP since 2005, has joined the DCCPS Office of the Director to serve as a Senior Advisor on special projects. Dr. Seminara has more than 20 years of experience in intramural and extramural programs at the National Institutes of Health (NIH), and she has been integral to the expansion of NCI's extramural genetic epidemiology portfolio. During her time in EGRP, Dr. Seminara led the design, implementation, and fostering of a thriving network of more than 60 interdisciplinary and translational cancer epidemiology consortia with national and international reach. She also played a key role in the scientific coordination and evaluation of cancer cohorts by leading the development of an innovative approach to the support of cancer cohort infrastructures (Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts U01).

Dr. Seminara designed and implemented the Breast Cancer Family Registry and Colon Cancer Family Registry cohorts and was part of a team that made substantial contributions to the development of NCI and NIH policies related to genome-wide association studies. She also co-led the Genetic Associations and Mechanisms in Oncology (GAME-ON): A Post-Genome Wide Association Initiative, served as EGRP's liaison to the OncoArray Network, was a part of the steering committee for NCI's Cohort Consortium, and launched the Cancer Epidemiology Descriptive Cohort Database.

EGRP thanks Drs. Khoury and Seminara for their many years of contributions to the Program and looks forward to the new perspectives and opportunities that Dr. Helzlsouer will bring as Associate Director.
 
Reminder of Budget and Data-Sharing Requirements for Large-Budget Grant Applications Reminder
Don_t Forget sticky note
NCI and the NIH require grant applications with requested budgets of $500,000 or more in subtotal direct costs in any one year to request approval before submitting proposals to NIH's Center for Scientific Review (CSR). Approval for applications assigned to NCI's Division of Cancer Control and Population Sciences (DCCPS), of which the Epidemiology and Genomics Research Program (EGRP) is a part, must be sought in the form of an Awaiting Receipt of Application (ARA).

Although comprehensive details about materials and deadlines for submitting ARAs to EGRP can be found on the EGRP website, this article highlights two important application requirements that frequently are overlooked.

Including Total Costs in Your ARA Budget

Although NIH policy on ARAs requires estimations of direct costs, applications to DCCPS also must include estimations of total costs. For all years proposed, applicants must list subtotals of direct costs, total direct costs, and total costs.

Data Sharing Plans for the NIH Genomic Data Sharing (GDS) Policy

A data sharing plan is now required for all research that falls within the scope of the new NIH Genomic Data Sharing (GDS) Policy. Details on when the policy applies and examples of projects affected by it are available on NCI's new Genomic Data Sharing (GDS) Policy web page.

Failure to provide this information with the initial ARA request could result in critical delays of the ARA approval for applicants. Learn more about the materials required for submitting an ARA, deadlines, and frequently asked questions, or contact the appropriate EGRP Program Director for additional assistance.
 
Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute | 9609 Medical Center Drive | 4 East, MSC 9763 | Bethesda | MD 20892


Contact Us | Privacy Policy | Accessibility | FOIA

U.S. Department of Health and Human Services
National Institutes of Health | National Cancer Institute | USA.gov